Clinical Trial Update: Utilization of Target Ranges to Treat Parkinson's Disease With the PKG [NA]

View source ↗

Summary

Clinical trial update indicates termination for a Parkinson's disease study evaluating target ranges with PKG technology; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: Global Kinetics Corporation | Conditions: Parkinson Disease | NA | Status: TERMINATED | Results posted: 2022-02-08